The most valuable asset of SPARK is the unique partnership between the university and industry experts
SPARK TEL AVIV is a mentoring program that was created to support the academic efforts of translating discoveries into therapeutics that address unmet medical needs.
SPARK TEL AVIV program is a unique partnership between university and industry experts dedicated to advance academic discoveries from laboratory to patient care.
SPARK TEL AVIV was modeled after the successful SPARK Stanford program, and is a part of a powerful SPARK Global network, with over 50 centers in academic institutions worldwide.
The program is designed to de-risk projects with high potential impact, addressing critical unmet medical needs for any medical indication.
Building upon Tel Aviv University's technological innovation and with 17 affiliated medical centers, SPARK TEL AVIV provides a cost-effective and efficient model to generate a proof of concept using industry standards.
SPARK TEL AVIV is the unique cross-sector partnership between the university and industry experts. Our goal is to establish a unique ecosystem program that will help to accelerate the Tel Aviv university-affiliated medical centers' academic inventions, from bench to clinic.
Our Mission Statement
- To help academics overcome the obstacles involved in moving their early discoveries from bench to bedside.
- To educate faculty, physicians, postdoctoral fellows, and graduate students on the translational research process and path to clinical application, so that the development of promising discoveries becomes second nature to our institution.
- To develop more cost-effective and innovative approaches to drug development, biomarkers, as well as digital health and Bio-convergence technologies. This is performed by close collaboration with the university’s leading drug discoveries core facilities, and entrepreneurship programs as well as the affiliated medical centers.
- To support "Give back to society" and drug repurposing projects, which are always suffering from limited funding.